• TRADE NAME: Diprivan (AstraZeneca)
  • INDICATIONS: Induction and maintenance of anesthesia
  • CLASS: Anesthetic; general
  • HALF-LIFE: initial: 40 minutes; terminal: 3 days
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    Zinc

Please login to view the rest of this drug profile.

Page last updated 04/08/2025

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric